Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Respiratory Infections specialty page provides respiratory infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Proposed Budget Cuts to Global Health Might Be Bad Medicine for State Economies: Public Health Watch Report
A new report by Global Health Technologies Coalition assesses the economic impact of cuts to global health R&D on the economies of US states.
Universal Influenza Vaccine Candidate to Begin Clinical Trial in United States
A phase 2 trial of an experimental universal flu vaccine is moving forward with sponsorship from The National Institute of Allergy and Infectious Diseases.
Ibrutinib Linked to Serious Infections in Patients with Lymphoid Cancer
A recent study finds that ibrutinib may be associated with serious infections in patients with lymphoid cancer.
<i>Contagion</i>® Launches Peer Exchange on Battling Against Resistant Pseudomonas Infections
Specialists discuss causes and frontline prevention strategies in the infectious disease space.
Significant Enrollment Milestone Met in Phase 3 Trial of Novavax's RSV Vaccine
Novavax announces that enrollment in phase 3 Prepare trial has reached approximately 4,600 participants, of whom, at least 3,000 have received the RSV F vaccine.
Smartphone App Offers Alternative Treatment Monitoring for Tuberculosis Patients
Tuberculosis treatment is long and rigorous, but a new study by Johns Hopkins School of Medicine suggests that a smartphone application may help patients adhere to their daily medication regimens.
Controlling <i>Legionella</i>—Room for Improvement in Clinical Practices & Water Management
A recent survey explores prevention practices for Legionnaires’ disease and water management programs in health care facilities.
Treatment Options to Address the Threat of Carbapenem-Resistant Enterobacteriaceae
New agents are in development, but none represent a magic bullet for the problems that CRE infections present.
Big advances in treatment can